Talk:Sanofi–GSK COVID-19 vaccine: Difference between revisions

Content deleted Content added

Inline

Revision as of 16:55, 23 April 2023

This is the talk page for discussing improvements to the Sanofi–GSK COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

This article has not yet been rated on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

COVID-19 Start‑class Mid‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Medicine Start‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Pharmacology Start‑class Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

"VidPrevtyn Beta®" listed at Redirects for discussion

A discussion is taking place to address a potential problem with the redirect VidPrevtyn Beta® and it has been listed for discussion. Readers of this page are welcome to participate at Wikipedia:Redirects for discussion/Log/2023 February 12 § VidPrevtyn Beta® until a consensus is reached. Clovermoss🍀 (talk) 01:09, 12 February 2023 (UTC)[reply]

Change in ATC code

The WHO has updated the ATC code for COVID-19 vaccines. The marketing authorisations may still need to be updated, but the WHO has already implemented these ATC codes. In the case of this vaccine from Sanofi and GSK, as it relates to a recombinant subunit vaccine, the ATC code to use is J07BN04.

WHOCC - ATC/DDD Index Classicwikip (talk) 16:55, 23 April 2023 (UTC)[reply]

@@ Line 9: / Line 9: @@
 [[File:Information.svg|30px]]
 A discussion is taking place to address a potential problem with the redirect <span class="plainlinks">[//en.wikipedia.org/enwiki/w/index.php?title=VidPrevtyn_Beta%C2%AE&redirect=no VidPrevtyn Beta®]</span> and it has been listed [[Wikipedia:Redirects for discussion|for discussion]]. Readers of this page are welcome to participate at {{slink|Wikipedia:Redirects for discussion/Log/2023 February 12#VidPrevtyn Beta®}} until a consensus is reached. <!-- from Template:RFDNote --> [[User:Clovermoss|<span style="color:darkorchid">Clovermoss</span><span style="color:green">🍀</span>]] [[User talk:Clovermoss|(talk)]] 01:09, 12 February 2023 (UTC)
+== Change in ATC code ==
+The WHO has updated the ATC code for COVID-19 vaccines. The marketing authorisations may still need to be updated, but the WHO has already implemented these ATC codes. In the case of this vaccine from Sanofi and GSK, as it relates to a recombinant subunit vaccine, the ATC code to use is J07BN04.
+[https://www.whocc.no/atc_ddd_index/?code=J07BN&showdescription=no WHOCC - ATC/DDD Index] [[User:Classicwikip|Classicwikip]] ([[User talk:Classicwikip|talk]]) 16:55, 23 April 2023 (UTC)